Profile: Dr. Tony Bonanzino
While employed by the large German pharmaceutical company Bayer AG, Tony was sent to Spokane, Washington for an assignment at the Bayer subsidiary, Hollister-Stier Labs, a small pharmaceutical and bio-technology company. When Bayer AG announced that it would sell Hollister-Stier Laboratories, Tony decided to lead a team to negotiate with Bayer for a leveraged buyout of Hollister-Stier Laboratories.
Dr. Bonanzino became the new President and CEO and immediately restructured the company, totally changing the firm’s management style. He indicated that he eliminated everything he perceived as employee abuse and invited input from his employees. In the process he turned an unprofitable subsidiary of Bayer AG into a strong and profitable separate company with its own corporate identity.
Tony also earned a Ph.D. in Leadership Studies from Gonzaga University, and continues to invest a great deal of his time in community projects and various non-profit organizations. He coaches young people in various team sports and still teaches one class each semester at the School of Business at Gonzaga University. He discusses his leveraged buyout of Hollister-Stier Labs as a case study at the Gonzaga School of Business. Dr. Bonanzino continues to run his successful firm, Hollister-Stier Laboratories, while serving in a number of leadership posts in the Spokane business community.